Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339261 · ClinicalTrials.gov registry record
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
A clinical trial of Lupus, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 716
- Enrollment target
- 1
- Study location
NCT00339261: Completed study of Lupus, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00339261 is a study of Lupus that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 716 participants, above the 230-participant average among 13 other Lupus trials with a reported enrollment target (211% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339261, a study of Lupus, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 716 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a continuing follow-up of patients with systemic lupus erythematosus (SLE) and control subjects enrolled in the Carolina Lupus Study and the University of North Carolina (UNC) Lupus Nephritis Study. SLE is a severe, chronic, disabling autoimmune disease that significantly affects health and quality of life. The disease most often affects young to middle-aged adults, and therefore can also affect work and disability. There is currently little information on work-related disability related to SLE. The goals of the current study are to: * Determine health and work status of patients and controls in the Carolina Lupus Study and the UNC Lupus Nephritis Study; * Develop and test methods for obtaining disease data from university- and community-based physicians in the study area; * Examine the associations between sociodemographic, work-related factors, disease damage, and work disability among SLE patients and controls; and * Assess the role of demographic and socioeconomic factors, psychosocial attributes, and potentially modifiable behavior or environmental factors (e.g., smoking, occupational exposures, medication compliance) in disease damage measures, and in the increased severity of disease among African-American patients. Patients and control subjects enrolled in the Carolina Lupus Study and the University of North Carolina Lupus Nephritis Study are eligible for this protocol. Subjects will participate in a 30-minute telephone interview that includes questions related to their current health status, medical care utilization, work and disability issues, psychosocial attributes (e.g., helplessness, social support), and changes in environmental exposures since the previous follow-up interview in 2001. With the patients' permission, disease damaged will be assessed using a standardized form to be completed by the patients' physician or using information obtained from the patient's medical record.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Environmental Health Sciences (NIEHS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 716 participants |
| Start Date | 2003-12-16 |
| Est. Completion | 2006-10-26 |
What the finished NCT00339261 record still lists
NCT00339261 is an observational study that tracks outcomes without assigning an intervention. The registered 716 participants enrollment target is mid-sized for trials with a published cap, above the 230-participant average among 13 other Lupus trials with a reported enrollment target (211% higher).
The record links to 1 condition, with Lupus appearing as the primary indexed condition, and to 0 interventions.
NCT00339261 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00339261 about?
NCT00339261 is a clinical study titled "Disease Progression and Activity in Patients With Systemic Lupus Erythematosus". This study is a continuing follow-up of patients with systemic lupus erythematosus (SLE) and control subjects enrolled in the Carolina Lupus Study and the University of North Carolina (UNC) Lupus Nephritis Study. SLE is a severe, chronic, disabling autoimmune disease that significantly affects healt...
What is the current status of trial NCT00339261?
This trial is currently completed. The enrollment target is 716 participants. The study started on 2003-12-16. Estimated completion is 2006-10-26.
What conditions does trial NCT00339261 study?
This clinical trial studies the following conditions: Lupus.
Who is sponsoring clinical trial NCT00339261?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00339261 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lupus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00339261's enrollment target sits among peer trials
716 2nd of 13 the highest of 13 other Lupus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lupus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RECRUITING · Phase 1
-
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
RECRUITING · NA
-
Safety and Efficacy of ONT01 in Lupus
RECRUITING · Early Phase 1
-
Patient-Centered Assessment of Symptoms and Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI